SAGE Therapeutics Inc (SAGE) stock is lower by -10.46% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives SAGE stock a score of 60 out of a possible 100.
That score is primarily influenced by a long-term technical score of 89. SAGE’s score also includes a short-term technical score of 56. The fundamental score for SAGE is 36. In addition to the average rating from Wall Street analysts, SAGE stock has a mean target price of $203.93. This means analysts expect the stock to gain 31.02% over the next 12 months.
What’s Happening with SAGE Stock Today
SAGE Therapeutics Inc (SAGE) stock has fallen -1.92% while the S&P 500 is lower by -0.1% as of 3:25 PM on Thursday, Mar 14. SAGE is lower by -$3.05 from the previous closing price of $158.70 on volume of 229,218 shares. Over the past year the S&P 500 is up 2.14% while SAGE is lower by -10.46%. SAGE lost -$8.06 share in the over the last 12 months.